Rimegepant sulfate is a pharmaceutical raw material that functions as a calcitonin gene-related peptide (CGRP) receptor antagonist. It is the salt form of rimegepant, used in the manufacturing of medications for migraine management.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1374024-48-2
Rimegepant
pharmaceutical raw material
Ubrogepant
pharmaceutical raw material
Atogepant
pharmaceutical raw material
3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
pharmaceutical raw material
Ribociclib succinate
pharmaceutical raw material
Rociletinib
pharmaceutical raw material
Trilaciclib
pharmaceutical raw material
(5R,6R,9S)-Rimegepant
pharmaceutical raw material
bis([(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl] 4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate);sulfuric acid;trihydrate
SOGUOEZRYKUOHR-CQZKMDJHSA-N
C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6.C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6.O.O.O.OS(=O)(=O)O